Clinical Trial: A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694557) titled 'A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection' on July 02.

Brief Summary: A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV)

Intervention: DRUG: YKYY025 group

intramuscular, a single intramuscular injection of the corresponding dose of YKYY025 for injection

DRUG: YKYY025 Placebo group

intramuscular, a single intramuscular injection of the corresponding dose of YKYY025 Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing You...